Portage Biotech Inc
NASDAQ:ATON
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Portage Biotech Inc
NASDAQ:ATON
|
VG |
|
A
|
Asics Corp
OTC:ASCCY
|
JP |
|
Clinuvel Pharmaceuticals Ltd
F:UR9
|
AU |
|
F
|
Fuyao Glass Industry Group Co Ltd
F:4FG
|
CN |
|
O
|
Osmosun SA
PAR:ALWTR
|
FR |
|
S
|
Star Entertainment Group Ltd
F:EE9
|
AU |
|
Purple Innovation Inc
NASDAQ:PRPL
|
US |
|
Compumedics Ltd
ASX:CMP
|
AU |
|
C
|
Carrier Global Corp
F:4PN
|
US |
|
N
|
Netbrands Corp
OTC:NBND
|
US |
|
E
|
Emerson Electric Co
XMUN:EMR
|
US |
|
A
|
Alpha Services and Holdings SA
ATHEX:ALPHA
|
GR |
|
Credit Agricole SA
MIL:ACA
|
FR |
|
Arrow Electronics Inc
NYSE:ARW
|
US |
|
Abivax SA
PAR:ABVX
|
FR |
|
Hitachi Ltd
F:HIA1
|
JP |
|
Cboe Global Markets Inc
F:C67
|
US |
|
E
|
Emerson Electric Co
XBER:EMR
|
US |
|
O
|
Oddity Tech Ltd
NASDAQ:ODD
|
IL |
|
Ansell Ltd
ASX:ANN
|
AU |
|
SK Rosgosstrakh PAO
MOEX:RGSS
|
RU |
|
T
|
Teekay Corp
XMUN:TCD
|
BM |
|
I
|
I3 Verticals Inc
F:V1K
|
US |
|
Fervi SpA
MIL:FVI
|
IT |
Bankruptcy Probability
Portage Biotech Inc's probability of bankruptcy is Hidden . The solvency score is Hidden .
We take all the information about a company's solvency, such as how easily it can pay interest on outstanding debt, how much cash it has, the amount of debt, and more, and use it to estimate the probability of bankruptcy.
Solvency Ratios
Solvency Ratios Comparison
Portage Biotech Inc Competitors
| Country | Company | Market Cap | D/E | D/A |
Interest Coverage |
Altman Z-Score |
Quick Ratio |
Current Ratio |
Cash Ratio |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| VG |
|
Portage Biotech Inc
NASDAQ:ATON
|
10.7m USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| FR |
|
Pharnext SCA
OTC:PNEXF
|
6T USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| JP |
|
Takara Bio Inc
TSE:4974
|
120.4T JPY |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Abbvie Inc
NYSE:ABBV
|
462.5B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Amgen Inc
NASDAQ:AMGN
|
239.6B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Gilead Sciences Inc
NASDAQ:GILD
|
185.7B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
141.1B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
E
|
Epizyme Inc
F:EPE
|
94.1B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
88.1B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| NL |
|
argenx SE
XBRU:ARGX
|
57.1B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| AU |
|
CSL Ltd
ASX:CSL
|
84B AUD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Portage Biotech Inc's probability of bankruptcy is Hidden .
The probability of bankruptcy is estimated using credit risk models that assess financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, Portage Biotech Inc has no debt.
You can find a full breakdown on its Balance Sheet.
